In Vivo Test-retest Quantitative Characterization of Echo Planar Imaging Apparent Diffusion Coefficient Reproducibility for Head and Neck Cancers on a 1.5T MR-Linac Platform: Technical Validation using QIBA Metrology
Preprint
Abstract
Background and Purpose: To detect changes in apparent diffusion coefficient (ADC) values during radiation therapy for biological image-guided adaptive radiation therapy, the variability in ADC must be characterized. We evaluated the reproducibility of ADC values in head and neck cancers on a 1.5T MR-linac. Methods: 39 head and neck cancer patients (36 primary tumors, 55 lymph nodes) were imaged with echo-planar imaging diffusion-weighted MRI on a 1.5T MR-linac at two time points before the start of radiation therapy. Mean and median ADC values and volume were measured for each lesion. Absolute and percent reproducibility coefficients (RC) were calculated. Linear regression analyses and F-tests were performed to determine whether lesion volume or time between scans impacted reproducibility. Results: For primary tumors & lymph nodes: mean ADC, median ADC, and volume were 1.27 ± 0.33 mm 2 /s & 1.17 ± 0.34 mm 2 /s, 1.25 ± 0.35 & 1.16 ± 0.37 mm 2 /s, and 8.8 ± 12.3 cm 3 & 6.5 ± 7.2 cm 3 , respectively. RC values of mean ADC were 0.355 mm 2 /s & 0.355 mm 2 /s for tumors & nodes, and %RC values were 29.1% & 31.1%; values were very similar for median ADC. Reproducibility was not significantly correlated with either volume or scan interval, but a trend of poorer reproducibility in smaller volumes was observed. Conclusion: Considering previous reports that the optimal %ΔADC threshold for response prediction in head and neck cancers is around 15-30%, this sequence on the MR-linac has acceptable reproducibility for detecting larger ADC changes but may still miss some clinically significant changes.Keywords
This publication has 37 references indexed in Scilit:
- Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working GroupEuropean Journal of Cancer, 2021
- Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trialsJournal of Magnetic Resonance Imaging, 2018
- Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imagingEuropean Journal of Radiology, 2017
- Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory‐Head and Neck ModuleCancer, 2014
- Diffusion-weighted imaging in head and neck squamous cell carcinomas: A systematic reviewHead & Neck, 2013
- An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer centerCancer, 2012
- Functional Outcomes after Chemoradiotherapy of Laryngeal and Pharyngeal CancersCurrent Oncology Reports, 2012
- Imaging parameter effects in apparent diffusion coefficient determination of magnetic resonance imagingEuropean Journal of Radiology, 2011
- Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinomaEuropean Radiology, 2010